SCHEMBL93014

SCHEMBL93014

Cc1ccc(CO)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL11464572 0.93 PRMT6 (0.59) —
SCHEMBL1681056 0.91 PRMT6 (0.52) —
SCHEMBL8571719 0.84 DPP4 (0.56) —
SCHEMBL5534627 0.80 — —
SCHEMBL2229904 0.80 — —
SCHEMBL23665620 0.78 PRMT6 (0.58) —
SCHEMBL10017405 0.78 PRMT6 (0.65) —
SCHEMBL79698 0.77 PRMT6 (0.47) —
SCHEMBL96145 0.76 — —
SCHEMBL6844117 0.75 PRMT6 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673137-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 — — EP disclosed
WO-2024182736-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
CN-109069514-B Antibacterial compound and application thereof 结核病药物开发全球联盟公司 2023-12-29 — — CN disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
WO-2023141511-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY (US) 2023-07-27 — — WO disclosed
WO-2023107597-A2 BICYCLIC HETEROAROMATIC AMIDE COMPOUNDS AND USES THEREOF Kineta, Inc. (US) 2023-06-15 — — WO disclosed
US-11591323-B2 Muscarinic agonists as non-steroidal and non-opioid analgesics and methods of use thereof Barry university (US) 2023-02-28 — — US disclosed
US-20230045960-A1 SUBSTITUTED HETEROAROMATIC PYRAZOLO-PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-02-16 — — US disclosed
CN-115667269-A Pyridone-containing fused ring derivative inhibitor, and preparation method and application thereof 上海翰森生物医药科技有限公司 2023-01-31 — — CN disclosed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 — — WO disclosed
WO-1993003719-A1 ARYLALKYLETHER AND ARYLALKYLTHIOETHER INHIBITORS OF LIPOXYGENASE ENZYME ACTIVITY ABBOTT LABORATORIES (US) 1993-03-04 — — WO disclosed
US-5183818-A Also for inhibiting leukotriene biosynthesis ABBOTT LABORATORIES (US) 1993-02-02 — — US disclosed
EP-0210647-B1 PYRIDAZINONE DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND INSECTICIDAL COMPOSITIONS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-10-28 — — EP disclosed
US-4910201-A With an ether substituted in position 5 NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1990-03-20 — — US disclosed
EP-0210647-A2 Pyridazinone derivatives, process for preparation thereof and insecticidal compositions NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1987-02-04 — — EP disclosed
US-4256878-A THIENYL COMPOUNDS, ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 1981-03-17 — — US disclosed
US-4230872-A ANTITUMOR AGENTS, THIENYL-3,7-DIMETHYLNONA-2,4,6,8-TETRAENE HOFFMANN-LA ROCHE INC. (US) 1980-10-28 — — US disclosed
US-4116975-A 9-THIENYL-3,7-DIMETHYLNONA-2,4,6,8-TETRAENES, ANTITUMOR HOFFMANN-LA ROCHE INC. (US) 1978-09-26 — — US disclosed
US-4061656-A ANTITUMOR HOFFMANN-LA ROCHE INC. (US) 1977-12-06 — — US disclosed
Send feedback